NYSE:HQL (USA)

Tekla Life Sciences Investors $ 20.74 -0.03 (-0.14%)

Volume:
69,298
Avg Vol (1m):
78,530
Market Cap $:
495.34 Mil
Enterprise Value $:
495.34 Mil
P/E (TTM):
4.04
P/B:
1.02
Warning! GuruFocus has detected 3 Medium warning signs with HQL. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for HQL (Tekla Life Sciences Investors) from 1990 to Jan 25 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Tekla Life Sciences Investors stock (HQL) PE ratio as of Jan 25 2021 is 4.04. More Details

Tekla Life Sciences Investors PE Ratio (TTM) Chart

EMBED

Tekla Life Sciences Investors PE Ratio (TTM) Historical Data

Total 478
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
Tekla Life Sciences Investors PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2021-01-254.0 2020-11-233.6
2021-01-224.0 2020-11-203.6
2021-01-214.0 2020-11-193.6
2021-01-204.1 2020-11-183.6
2021-01-194.0 2020-11-173.6
2021-01-184.0 2020-11-163.6
2021-01-154.0 2020-11-133.6
2021-01-144.0 2020-11-123.5
2021-01-134.0 2020-11-113.5
2021-01-124.0 2020-11-103.5
2021-01-113.9 2020-11-093.5
2021-01-083.9 2020-11-063.5
2021-01-073.9 2020-11-053.5
2021-01-063.8 2020-11-043.5
2021-01-053.8 2020-11-033.3
2021-01-043.8 2020-11-023.3
2021-01-013.8 2020-10-303.3
2020-12-313.8 2020-10-293.4
2020-12-303.9 2020-10-283.4
2020-12-293.9 2020-10-273.4
2020-12-283.9 2020-10-263.4
2020-12-253.9 2020-10-233.5
2020-12-243.9 2020-10-223.5
2020-12-233.9 2020-10-213.4
2020-12-223.9 2020-10-203.5
2020-12-213.9 2020-10-193.4
2020-12-183.9 2020-10-163.5
2020-12-173.9 2020-10-153.5
2020-12-163.8 2020-10-143.6
2020-12-153.8 2020-10-133.6
2020-12-143.8 2020-10-123.6
2020-12-113.7 2020-10-093.6
2020-12-103.7 2020-10-083.6
2020-12-093.7 2020-10-073.6
2020-12-083.7 2020-10-063.5
2020-12-073.7 2020-10-053.5
2020-12-043.7 2020-10-023.4
2020-12-033.7 2020-10-013.4
2020-12-023.7 2020-09-303.4
2020-12-013.7 2020-09-293.4
2020-11-303.6 2020-09-283.4
2020-11-273.7 2020-09-250.0
2020-11-263.6 2020-09-240.0
2020-11-253.6 2020-09-230.0
2020-11-243.6 2020-09-220.0

Tekla Life Sciences Investors PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Financial Services » Asset Management » NAICS : 523930 NAICS : 6282
Traded in other countries HQL.USA
Address 100 Federal Street, 19th Floor, Boston, MA, USA, 02110
Tekla Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in the securities of life sciences companies. The fund invests in the securities of public and private companies.